Genitourinary Cancer
From the Journals
AI holds its own against pathologists for prostate cancer diagnosis
Deep learning algorithms have shown a high level of agreement with expert uropathologists in diagnosing and grading prostate cancer.
Latest News
Experts disappointed by NICE’s decision to reject prostate cancer drug
The Institute of Cancer Research said the decision by NICE put patients in England and Wales at a disadvantage to those in Scotland where the...
Latest News
For equality in prostate cancer outcomes, seek equality in treatment
Black men in radiotherapy clinical trials had similar outcomes to White men.
Conference Coverage
Cancer risk tied to some manufactured foods
The results of three European studies support the removal of trans fatty acids, nitrites, and nitrates from food products.
Rare Diseases Report 2021
Rare GU cancers: Overcoming obstacles through collaboration, novel trial design
Investigators are meeting the challenge of dealing with rare genitourinary cancers through collaboration, novel treatment efforts, and clinical...
Commentary
LGBTQ health care: There is reason to be hopeful
“LGBTQ/rainbow health has been harmfully treated by the system, by both intention and by ignorance.”
Latest News
After doc uproar, NCCN reverses prostate cancer guidance
This advice aligns closely with the group’s initial recommendation, published over a decade ago.
Latest News
Shock, disbelief as NCCN changes prostate cancer guidance
“To suggest for a millisecond that active surveillance isn’t the preferred method for low-risk men is bizarre thinking ... Is this 1980?”
From the Journals
Urine test for prostate cancer signals amount of aggressive tumor
“PUR will also be useful for monitoring disease in men that do not currently require treatment and flag up the emergence” of aggressive disease....
From the Journals
Prostate cancer risk higher with Lynch syndrome variants
The risk of prostate cancer was higher in men with certain pathogenic variants in mismatch repair genes that characterize the Lynch syndrome,...
From the Journals
Severe COVID two times higher for cancer patients